Proietti, R, Rivera-Caravaca, JM, López-Gálvez, R, Harrison, SL, Marín, F, Underhill, P, Shantsila, E, McDowell, G, Vinciguerra, M, Davies, R, Giebel, C, Lane, DA and Lip, GYH (2023) Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of Clinical Medicine, 12 (8). ISSN 2077-0383

Proietti, R, Rivera-Caravaca, JM, López-Gálvez, R, Harrison, SL, Buckley, B, Marin, F, Underhill, P, Shantsila, E, Shantsila, A, Davies, R, Lane, D and Lip, GYH (2023) Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis. Clinical Cardiology. ISSN 0160-9289

Proietti, R, Rivera-Caravaca, JM, Harrison, SL, Buckley, BJR, López-Gálvez, R, Marín, F, Fairbairn, T, Madine, J, Akhtar, R, Underhill, P, Field, M and Lip, GYH (2023) Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis. Internal and Emergency Medicine. ISSN 1828-0447

Rivera-Caravaca, JM, Harrison, SL, Buckley, BJR, Fazio-Eynullayeva, E, Underhill, P, Marin, F and Lip, GYH (2021) Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases. Cardiovascular Diabetology, 20 (1). ISSN 1475-2840

Rivera-Caravaca, JM, Buckley, BJR, Harrison, SL, Fazio-Eynullayeva, E, Underhill, P, Marin, F and Lip, GYH (2021) Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes. Thrombosis Research, 205. pp. 1-7. ISSN 0049-3848